We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Why are clinical trials 85% white?

Why are clinical trials 85% white?

Learn how we’re advancing the inclusion of underrepresented groups in research, development, and care delivery to enrich scientific insights, achieve health equity and ensure access for all.